Usman Choudhry, DO
Cardiovascular Disease · Morristown, NJNPI 1497045504
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $2,134 of the $3,498 with a category attached, or 61.0%. Abbott accounts for 63.2% of it on its own, with 19 other manufacturers making up the rest. Reporting peaked in 2019 at $1,993 and has fallen 93.6% since, to $128 in 2025.
Across 102 payments — averaging $34.29 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$2K
- Actelion Pharmaceuticals US, Inc.$249
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$199
- Alnylam Pharmaceuticals Inc.$126
- Pfizer$107
- E.r. Squibb & Sons, L.L.C.$98
- plus $510 from 14 others
What the payments were for
- Travel & lodging$1,15633%
- Food & beverage$2,13461%
- Education$2086%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 26 | $2,209 |
| Actelion Pharmaceuticals US, Inc. | 16 | $249 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 7 | $199 |
| Alnylam Pharmaceuticals Inc. | 7 | $126 |
| Pfizer | 7 | $107 |
| E.r. Squibb & Sons, L.L.C. | 5 | $98 |
| Merck | 6 | $86 |
| United Therapeutics Corporation | 6 | $82 |
| Boehringer Ingelheim | 5 | $75 |
| AstraZeneca | 4 | $55 |
| Amgen | 3 | $45 |
| Novartis | 2 | $32 |
| Baxter Healthcare | 1 | $23 |
| Daxor Corporation | 1 | $21 |
| Chiesi USA, Inc. | 1 | $18 |
| Impulse Dynamics (USA) Inc. | 1 | $16 |
| Sanofi | 1 | $15 |
| Novo Nordisk | 1 | $15 |
| Bayer | 1 | $14 |
| Akcea Therapeutics, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- HeartMate PHP$1,450
- HeartMate II LVAS$208
How this compares
$3,498 in reported general payments places this provider in the 55th percentile of 1,006 cardiovascular disease providers in New Jersey.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other cardiovascular disease in Morristown
- Gennaro GiustinoMorristown$135K
- Konstantinos KoulogiannisMorristown$123K
- Linda GillamMorristown$61K
- Robert KippermanMorristown$48K
- Marc CohenNewark$762K
- Peter FarrugiaColts Neck$600K
- Felix Dailey-SterlingGuttenberg$568K
- Ramzan ZakirNew Brunswick$342K
- Richard KovachBrowns Mills$300K
- Andrea RussoCamden$293K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.